Dose determination for molecularly targeted therapies: Much Ado About Nothing.
START, Clinical Research, San Antonio, Texas.
Anthony
A
Tolcher
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics
D000970:Antineoplastic Agents